Literature DB >> 33644678

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology.

Frances Tse1,2, Paul Moayyedi1,3, Kevin A Waschke4,5, Mark MacMillan2,6, Nauzer Forbes2,7, Matthew W Carroll2,8, Nicholas Carman2,9, Grigorios I Leontiadis1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33644678      PMCID： PMC7898369          DOI： 10.1093/jcag/gwaa046

Source DB:  PubMed          Journal:  J Can Assoc Gastroenterol        ISSN： 2515-2084


× No keyword cloud information.
  8 in total

Review 1.  Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.

Authors:  Evelina Croce; Christoph Hatz; Emile F Jonker; L G Visser; Veronika K Jaeger; Silja Bühler
Journal:  Vaccine       Date:  2017-02-03       Impact factor: 3.641

2.  Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-05-02       Impact factor: 17.586

3.  Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.

Authors:  Erica J Brenner; Ryan C Ungaro; Richard B Gearry; Gilaad G Kaplan; Michele Kissous-Hunt; James D Lewis; Siew C Ng; Jean-Francois Rahier; Walter Reinisch; Frank M Ruemmele; Flavio Steinwurz; Fox E Underwood; Xian Zhang; Jean-Frederic Colombel; Michael D Kappelman
Journal:  Gastroenterology       Date:  2020-05-18       Impact factor: 22.682

4.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

5.  Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.

Authors:  Shailendra Singh; Ahmad Khan; Monica Chowdhry; Mohammad Bilal; Gursimran S Kochhar; Kofi Clarke
Journal:  Gastroenterology       Date:  2020-06-06       Impact factor: 22.682

6.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-18       Impact factor: 17.586

7.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

8.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Authors:  Edward E Walsh; Robert W Frenck; Ann R Falsey; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; Kathleen Neuzil; Mark J Mulligan; Ruth Bailey; Kena A Swanson; Ping Li; Kenneth Koury; Warren Kalina; David Cooper; Camila Fontes-Garfias; Pei-Yong Shi; Özlem Türeci; Kristin R Tompkins; Kirsten E Lyke; Vanessa Raabe; Philip R Dormitzer; Kathrin U Jansen; Uğur Şahin; William C Gruber
Journal:  N Engl J Med       Date:  2020-10-14       Impact factor: 91.245
  8 in total
  5 in total

1.  Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study.

Authors:  Mohammad Shehab; Fatema Alrashed; Israa Abdullah; Ahmad Alfadhli; Hamad Ali; Mohamed Abu-Farha; Arshad Mohamed Channanath; Jehad Ahmed Abubaker; Fahd Al-Mulla
Journal:  Front Med (Lausanne)       Date:  2022-06-08

2.  Serological response to SARS-CoV-2 is attenuated in patients with inflammatory bowel disease and can affect immunization.

Authors:  Shaghayegh Baradaran Ghavami; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Seyed Mobin Khoramjoo; Maryam Farmani; Nesa Kazemifard; Tommaso Lorenzo Parigi; Silivio Danese; Hedieh Balaii; Ghazal Sherkat; Nasser Ebrahimi Daryani; Foroogh Alborzi; Hassan Vossoughinia; Mohammad Reza Zali
Journal:  JGH Open       Date:  2022-03-17

Review 3.  Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.

Authors:  Jennifer L Jones; Frances Tse; Matthew W Carroll; Jennifer C deBruyn; Shelly A McNeil; Anne Pham-Huy; Cynthia H Seow; Lisa L Barrett; Talat Bessissow; Nicholas Carman; Gil Y Melmed; Otto G Vanderkooi; John K Marshall; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2021-07-29

Review 4.  SARS-CoV-2 vaccination in patients with inflammatory bowel disease.

Authors:  Ralley E Prentice; Clarissa Rentsch; Aysha H Al-Ani; Eva Zhang; Douglas Johnson; John Halliday; Robert Bryant; Jacob Begun; Mark G Ward; Peter J Lewindon; Susan J Connor; Simon Ghaly; Britt Christensen
Journal:  GastroHep       Date:  2021-07-23

5.  Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain.

Authors:  Eric I Benchimol; M Ellen Kuenzig
Journal:  Aliment Pharmacol Ther       Date:  2022-07       Impact factor: 9.524
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.